PATENT CLAIM ANALYSIS

Application Number: 16020517
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "04400A"]

Abstract:
The method of treating delayed healing of a wound associated with diabetes includes administering to the wound a composition comprising an anti-senescence compound and a pharmaceutically acceptable carrier. The anti-senescence compound may be 18α-Glycyrrhetinic acid, a Caveolin-1 (Cav-1) inhibitory compound, or a Polymerase I Transcript Release Factor (PTRF-1) inhibitory compound. The anti-senescence compound may be effective in preventing and/or reversing premature cellular senescence. The anti-senescence compound may be effective in promoting healing of a wound, e.g., delayed or incompletely healed wound. The anti-senescence compound may be effective in promoting healing of a delayed healing wound or chronic wound of a diabetic patient, such as a diabetic ulcer or venous ulcer.

Claim (Index 8):
The method of treating delayed healing of a wound associated with diabetes as recited in  claim 1 , wherein the pharmaceutically acceptable carrier comprises pluronic acid.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 94.0
- Lexical Diversity: 2.03279
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15515927', '13717349', '15004372', '15455575', '12742250']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7661977499402874
- 35 USC 102 Novelty (BERT): 0.5114635587545365
- Combined Prediction Score: 0.7407243308217124
- Mean Citation Score: 244.00572000000005
- Max Citation Score: 250.33371
- Similarity Product: 157.27961454964046

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test